Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

Sir, you are no longer a maverick. We should have listened to you. It took over 40 years, but today, at the American Heart Association (AHA) Scientific Sessions 2019, we learned that you were right to ...

BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults ...

DALLAS – Prolonged ischemic time for free-tissue transfer in head and neck (H&N) reconstruction was not linked with intraoperative or postoperative complications, a researcher reported here. In the ...

PHILADELPHIA, PA (UPDATED)—After more than 10 years and $100 million, the International Study of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) has delivered a ...

Myocardial ischemia caused by ramped-up psychological stress is associated with poor clinical outcomes in patients who have previously had a myocardial infarction, new study results show. The research ...

PHILADELPHIA — Most patients with advanced chronic kidney disease (CKD) and moderate to severe ischemia at stress testing won't live longer or be any more protected from myocardial infarction (MI) if ...

DENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the launch of Cleerly ISCHEMIA, which recently received U.S.

Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — The medical community needs to understand that uncontrolled open artery ischemia is not benign ...

Coronary heart disease is the leading cause of death worldwide, and 3.8 million men and 3.4 million women die of the disease each year. After an acute myocardial infarction, early and successful ...